Published in
Taylor and Francis Group, Journal of Dermatological Treatment, 3(33), p. 1591-1597, 2021
DOI: 10.1080/09546634.2020.1869147
Links
Tools
Two-year Follow-up of a Dose Reduction Strategy Trial of Biologics Adalimumab, Etanercept, and Ustekinumab in Psoriasis Patients in Daily Practice
Journal article published in 2020 by
S. Atalay 
,
Jmpa M. P. A. van den Reek ,
Jmm M. M. Groenewoud ,
Pcm C. M. van de Kerkhof ,
W. Kievit ,
Emgj M. G. J. de Jong
,
Jmpa M. P. A. van den Reek ,
Jmm M. M. Groenewoud ,
Pcm C. M. van de Kerkhof ,
W. Kievit ,
Emgj M. G. J. de Jong
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 